Vokes, E E <br/><br/>
Escalating doses of interferon alpha-2A with cisplatin and concomitant radiotherapy: a phase I study.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  1993 
 - 203-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0344-5704 
<br/><br/><label>Standard No.: </label>10.1007/BF00686217  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Cisplatin--administration & dosage<br/>Combined Modality Therapy<br/>Dose-Response Relationship, Drug<br/>Female<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--administration & dosage<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasms--drug therapy<br/>Recombinant Proteins